Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




Clinical Trials

News from SCRIP

A Dietary Intervention Study on the Microbiome in Crohn's Disease Patients

Thursday, August 22, 2019 - 12:00pm

Condition:   Crohn Disease
Intervention:   Other: Soy based diet
Sponsors:   Case Western Reserve University;   University of California, Davis;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University Hospitals Cleveland Medical Center
Not yet recruiting
read more

Double Blind, Randomized, Controlled With Placebo Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO)

Thursday, August 22, 2019 - 12:00pm

Condition:   Diarrhea
Interventions:   Combination Product: Gelatin tannate (GT) + oral rehydration solution (ORS) + Zinc supplementation;   Combination Product: placebo + ORS + Zinc supplementation
Sponsor:   Ferrer Internacional S.A.
Not yet recruiting
read more

A Comparison of the Resection Rate for Cold and Hot Snare Polypectomy for 5-15 mm Colorectal Polyps

Monday, August 19, 2019 - 12:00pm

Condition:   Adenomatous Polyps
Interventions:   Procedure: Cold snare polypectomy;   Procedure: Hot snare polypectomy;   Procedure: Endoscopic margin observation method
Sponsor:   Yuqi He
Not yet recruiting
read more

Pages

Cardiovascular

Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients

Thursday, August 22, 2019 - 12:00pm

Conditions:   Myeloma Multiple;   Myeloma, Plasma-Cell;   Myeloma-Multiple;   Plasma Cell Myeloma
Interventions:   Drug: Carfilzomib;   Drug: Daratumumab;   Drug: Lenalidomide;   Drug: Dexamethasone
Sponsor:   Tel-Aviv Sourasky Medical Center
Recruiting
read more

Phase I/II Assessment of Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT

Thursday, August 22, 2019 - 12:00pm

Conditions:   Multiple Myeloma;   Relapsed Refractory Multiple Myeloma
Interventions:   Drug: Elotuzumab, pomalidomide, dexamethasone;   Drug: Anti-LAG-3 Monoclonal Antibody BMS-986016, pomalidomide, dexamethasone;   Drug: Anti-TIGIT Monoclonal Antibody BMS-986207, pomalidomide, dexamethasone
Sponsors:   Multiple Myeloma Research Consortium;   Bristol-Myers Squibb
Not yet recruiting
read more

Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma

Thursday, August 22, 2019 - 12:00pm

Conditions:   Multiple Myeloma in Relapse;   Plasmacytoma;   Daratumumab
Intervention:   Drug: Drug Combinations
Sponsor:   Seoul National University Hospital
Recruiting
read more

Pages

Publication Date: 
Friday, July 15, 2016 - 1:45pm
Category: 
Friday, July 15, 2016 - 1:45pm